Hospital
Williamston Hospital Corporation
Williamston Hospital Corporation was paid $2.31M by Medicaid between Jan 2018 and Jul 2023, across 64 billing codes. Its largest line is 99283, emergency room visit (moderate) — 41% of everything it billed.
33Billing provider infoWILLIAMSTON HOSPITAL CORPORATION
WILLIAMSTON, NC 27892
WILLIAMSTON, NC 27892
33aNPI1851362669assigned 01/30/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$2.31M
24GClaims59,552
24DCodes billed64
24AFirst – last monthJan 2018 – Jul 2023
Compared with peers
Next to other General Acute Care Hospital providers in North Carolina
Rank by total paid#74 of 92
Median peer was paid$11.47M
This provider vs. median0.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official COOPER, RANDY controls 18+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 13,404 | $370K | |
| 2019 | 10,880 | $309K | |
| 2020 | 7,619 | $205K | |
| 2021 | 8,791 | $443K | |
| 2022 | 11,259 | $644K | |
| 2023 | 7,599 | $337K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 41% | 10,820 | 9,671 | $937K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 31% | 6,923 | 6,023 | $719K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 6.2% | 1,228 | 1,022 | $143K |
| 70450 | Computed tomography, head or brain; without contrast material | 2.3% | 427 | 372 | $54K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 2.2% | 1,753 | 1,438 | $50K |
| 87428 | 2.1% | 706 | 630 | $49K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.9% | 8,059 | 6,722 | $45K |
| 80053 | Comprehensive metabolic panel | 1.5% | 5,221 | 4,404 | $34K |
| 71045 | Radiologic examination, chest; single view | 1.4% | 1,349 | 1,166 | $33K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 1.0% | 617 | 571 | $24K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.0% | 1,047 | 976 | $23K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 356 | 328 | $19K |
52 more codes
| 71046 | Radiologic examination, chest; 2 views | <1% | 265 | $18K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 49 | $16K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 2,037 | $14K |
| 81003 | <1% | 6,197 | $12K | |
| 94761 | <1% | 582 | $11K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 39 | $9K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 321 | $8K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 353 | $8K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 255 | $7K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 130 | $6K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 213 | $6K |
| 84484 | <1% | 1,522 | $6K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 367 | $5K |
| 36415 | Collection of venous blood by venipuncture | <1% | 3,579 | $5K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 75 | $4K |
| 94760 | <1% | 897 | $4K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 247 | $4K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 29 | $3K |
| 81025 | <1% | 314 | $3K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 412 | $2K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 29 | $2K |
| 83880 | <1% | 156 | $2K | |
| 86696 | <1% | 102 | $2K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 86 | $2K |
| 86592 | <1% | 345 | $1K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 62 | $1K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 113 | $1K |
| 86695 | <1% | 104 | $1K | |
| 83605 | <1% | 222 | $1K | |
| 94726 | <1% | 47 | $1K | |
| 86850 | <1% | 42 | $1K | |
| 80061 | Lipid panel | <1% | 61 | $973.98 |
| 94060 | <1% | 48 | $913.34 | |
| 94729 | <1% | 47 | $658.16 | |
| 83690 | <1% | 98 | $630.84 | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 375 | $609.33 |
| 85027 | <1% | 71 | $480.67 | |
| 84439 | <1% | 41 | $449.60 | |
| 87040 | <1% | 105 | $390.42 | |
| 87088 | <1% | 45 | $388.78 | |
| 84436 | <1% | 46 | $335.57 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 205 | $299.13 |
| 86762 | <1% | 13 | $214.80 | |
| 86803 | <1% | 13 | $213.48 | |
| 86787 | <1% | 13 | $192.60 | |
| 87340 | <1% | 13 | $139.08 | |
| 86901 | <1% | 42 | $135.67 | |
| 86900 | <1% | 42 | $135.67 | |
| 82962 | <1% | 88 | $131.90 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 62 | $57.71 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 44 | $38.85 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 0% | 383 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCOOPER, RANDY (SVP FINANCE OP/AUTHORIZED OFFICIAL)
| Provider | Location | Paid |
|---|---|---|
| Jackson Hospital Corporation | Jackson, KY | $34.90M |
| Deming Hospital Corporation | Deming, NM | $34.61M |
| Hospital of Louisa, INC. | Louisa, KY | $27.77M |
| Hospital of Barstow INC | Barstow, CA | $16.88M |
| Paintsville Hospital Company, LLC | Paintsville, KY | $15.46M |
| San Miguel Hospital Corporation | Las Vegas, NM | $13.21M |
| Tooele Hospital Corporation | Tooele, UT | $11.66M |
| Forrest City Arkansas Hospital Company LLC | Forrest City, AR | $7.42M |
| MMC of Nevada LLC | Mesquite, NV | $2.60M |
| Fort Payne Hospital Corporation | Fort Payne, AL | $2.60M |
| Waukegan Illinois Hospital Company LLC | Waukegan, IL | $2.30M |
| Southwest Kidney Institute Vascular Center LLC | Tempe, AZ | $850K |
| Evanston Hospital Corporation | Evanston, WY | $378K |
| Marion Hospital Corporation | Marion, IL | $220K |
| Anna Hospital Corporation | Anna, IL | $217K |
| National Healthcare of MT Vernon INC | Mount Vernon, IL | $158K |
| Red Bud Illinois Hospital Company LLC | Red Bud, IL | $36K |
| Tooele Hospital Corporation | Tooele, UT | $5K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.